MOTS-c (Mitochondrial Peptide)

The Residue That Oxidises So Others Do Not

UKPWritten and published by UK Peptides2 min readUpdated 3 cited sources

The short answer

Methionine oxidises readily to the sulfoxide, which is normally described as degradation. Uniquely among common oxidative modifications it is enzymatically reversible, so methionine can absorb oxidative insult repeatedly, functioning as a regenerable buffer rather than simply being damaged.

Key facts

Oxidation product
Methionine sulfoxide, +16 Da
Unusual property
Enzymatically reversible
Reducing enzymes
Methionine sulfoxide reductases
Consequence
Repeatable, not one-way
Proposed role
Antioxidant buffer
Key paper
Bender 2008, PNAS (PMID 18946048)

Why most oxidative damage is permanent

Oxidation of most amino acid side chains produces products the cell cannot undo. Carbonylation of lysine or arginine, oxidation of tryptophan and cleavage of the peptide backbone are terminal, and the only remedy is degrading the protein and building another. Damage of that kind accumulates.

Why methionine is different

Its thioether sulfur oxidises to the sulfoxide, and cells possess methionine sulfoxide reductases that reduce it back. That makes the modification a cycle rather than an endpoint. A methionine residue can be oxidised, restored and oxidised again, which is a very different relationship with reactive oxygen than any residue that is simply destroyed.

Research material referenced

MOTS-C 10mg, third-party HPLC tested

Buy MOTS-C · £24.99

How that becomes a defence

If methionine is preferentially oxidised, it intercepts oxidants that would otherwise reach residues where damage is permanent. Surface methionines effectively act as a sacrificial layer, and because the reductases restore them, the protective capacity regenerates rather than depleting. The residue is doing work by being vulnerable.

The argument Bender and colleagues made

That mitochondria increased methionine content deliberately, through the genetic code itself. Their 2008 PNAS paper argues adaptive antioxidant methionine accumulation in respiratory chain complexes explains why mitochondria use a deviant code. The AUA reassignment substitutes methionine for isoleucine, and the compartment doing so is the one producing the most reactive oxygen.

What this changes about reading a certificate

Nothing about handling: a +16 Da satellite still indicates oxidation, and oxidised material still differs from what was specified. But it reframes why a mitochondrial peptide is methionine-rich in the first place. The residues that make MOTS-c awkward to store are plausibly there for a reason, and vulnerability in a vial is not the same as vulnerability in a cell, because a cell has reductases and a vial does not.

Where the analogy stops

Regeneration requires enzymes. A lyophilised peptide in a vial has none, so oxidation there is one-way and cumulative in just the way the storage guidance assumes. The functional argument concerns methionine inside a living system; the handling concern concerns methionine in storage. Both are correct and they describe different situations.

Frequently asked questions

Is methionine oxidation reversible?

In cells, yes. Methionine sulfoxide reductases reduce it back, which is unusual among oxidative modifications.

How does that make it an antioxidant?

Preferential oxidation intercepts oxidants that would otherwise damage residues permanently, and the reductases regenerate the capacity.

Does this change storage advice?

No. A vial has no reductases, so oxidation there is one-way and cumulative. The functional role applies inside a living system.

Continue researching

Related guides and reference material.

Primary sources & clinical trials

Published papers, trial registrations, regulator pages and company announcements. Links open the original.

UKP

Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).

Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.

Corrections log

More MOTS-c (Mitochondrial Peptide) articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.